Acetylcholinesterase inhibitors (AChEI) and cognitive stimulation (CS) are the standard pharmacological and non-pharmacological treatments for Alzheimer’s disease (AD). The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.